About Elsavie
Elsavie, established in 2020, excels in promoting health and well-being, advancing biotech innovations, diagnostic tools, and gut health tracking. Provides microbiome test kits and a gut health tracking application for personal wellness. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarter Tallinn, Estonia
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website elsavie.com
- Social Facebook Instagram
- Legal Name Oü Elsavie
Apps and channels of Elsavie
Elsavie publishes 2 mobile apps with over 1K+ downloads.
Similar companies to Elsavie
10 companies that operate in the same segment as Elsavie (Gastroenterology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for gastrointestinal disorders, including linaclotide, are developed. | 1998 | Cambridge, Massachusetts, United States | USD 206.25 M | USD 296.15 M | 253 | |
Implantable battery-powered pumps for ascites removal are developed. | 2006 | Zurich, Switzerland | USD 35.5 M | – | – | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | – | – | |
Provider of a deep learning platform for detecting circulating cancer-related markers | 2014 | United States | USD 1.35 B | – | 533 | |
Developer of electrosurgical system and range of flexible endoscopic instruments | 2003 | Chepstow, Monmouthshire, United Kingdom | USD 20.84 M | USD 8.08 M | 141 | |
Non-invasive biomarker tests for colorectal cancer are developed. | 2015 | St. Louis, Missouri, United States | USD 218.95 M | – | – | |
Pendulum is focused on developing advanced probiotic solutions. | 2012 | San Francisco, California, United States | USD 109.5 M | – | 55 | |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed. | 2007 | Fremont, California, United States | USD 61.1 M | USD 407.32 M | 395 | |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases | 2009 | Ramat Gan, Tel Aviv District, Israel | USD 13.5 M | USD 288.27 K | 35 | |
Biologics are developed for cardio-metabolic and liver diseases. | 2007 | San Francisco, California, United States | USD 358.87 M | USD 330.53 M | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Elsavie
Elsavie was founded in 2020.
Elsavie is headquartered in Tallinn, Estonia.
Elsavie, established in 2020, excels in promoting health and well-being, advancing biotech innovations, diagnostic tools, and gut health tracking. Provides microbiome test kits and a gut health tracking application for personal wellness. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Elsavie operates through Oü Elsavie.
Yes. Elsavie publishes Gut Health Tracking & Insights and 1 more app, with over 1,000 downloads.